News

April 29, 2024

SyVento BioTech is excited to announce our participation in the highly anticipated 3rd Annual LNP Formulation & Process Development Summit taking place in Boston, MA, from April 29th to May 2nd, 2024. Our esteemed delegates, Dominik Lipka and Olga Długosz Grochowska, will be actively engaged in the summit, attending not only the core conference sessions but also delving deeper with […]

April 17, 2024

London, April 29-30, 2024 The LSX World Conference, a premier event in the life sciences industry, convened today in London, bringing together global leaders, innovators, and investors to explore the latest trends and advancements in healthcare, biotechnology, and pharmaceuticals. Hosted by Informa Connect, the conference promises to be a dynamic platform for networking, knowledge exchange, […]

April 17, 2024

Switzerland, renowned for its cutting-edge advancements in the field of biotechnology, once again played host to the prestigious Swiss BioTech Day in Basel. The event, held annually, serves as a pivotal platform for industry leaders, researchers, investors, and enthusiasts to converge, exchange ideas, and foster collaborations aimed at driving the future of biotech innovation. This […]

March 13, 2024

Syvento, a leading biotechnology company in RNA therapeutics, emerged at the recent RNA Leaders conference between March 13-14, 2024 in Basel, Switzerland. Throughout the event, Syvento showcased its innovative contributions to the field by exhibiting at booth no. 21. Visitors to the booth had the opportunity to engage with Syvento’s representatives, learn about the company’s […]

January 30, 2024

SyVento BioTech is committed to staying at the forefront of mRNA therapeutics development. Our participation in the upcoming 3rd mRNA Analytical Development Summit is a testament to this commitment. Representing us at this pivotal event are our CTO, Dominik Lipka PhD Eng., and Marcelina Radko-Zwierzyńska, Manager of Research and Quality Control Laboratory. The summit promises […]

October 18, 2023

Exciting developments are on the horizon! SyVento BioTech is proud to announce a partnership with the Faculty of Biochemistry, Biophysics, and Biotechnology (FBBB) at Jagiellonian University. Jagiellonian University’s FBBB is renowned for its contributions to modern biology. Combined with SyVento BioTech’s innovative technologies, this collaboration aims to push the boundaries of biotechnological research. Beyond joint […]

October 9, 2023

SyVento BioTech is delighted to announce the appointment of Kajetan Bartosik as its new Chief Executive Officer. With over 16 years in leadership at the MS Galleon Group, Kajetan Bartosik is renowned for building and leading top-performing teams. His time underscores his unwavering commitment and expertise. He’s successfully set up and transformed businesses, whether launching […]

September 27, 2023

LONDON, September 26, 2023 – The Polish-British Future of Healthcare Event, focusing on advancements in MedTech, BioTech, and scientific research, will soon take place at the Royal Society of Medicine. SyVento BioTech will be represented by Tomasz Piec, Chairman of the Supervisory Board, and Dominik Lipka, our CTO. International Cooperation in BioTech: A Business Imperative […]

September 11, 2023

SyVento BioTech Partners with LifeScience Kraków Cluster: A Global Vision with Local Roots In a strategic move that aims to consolidate our position as a leader in biotechnology and life sciences, SyVento BioTech is proud to announce our official partnership with the LifeScience Kraków Cluster. Established in 2006, the LifeScience Kraków Cluster has consistently served […]